Targeting human telomerase for cancer therapeutics-Reference-Cited by-同舟云学术

Targeting human telomerase for cancer therapeutics

Published:2004-06 Issue:1-2 Volume:45 Page:75-90
ISSN:0920-9069
Container-title:Cytotechnology
language:en
Short-container-title:Cytotechnology

Author:

Guittat Lionel,Alberti Patrizia,Gomez Dennis,De Cian Anne,Pennarun Gaëlle,Lemarteleur Thibault,Belmokhtar Chafke,Paterski Rajaa,Morjani Hamid,Trentesaux Chantal,Mandine Eliane,Boussin François,Mailliet Patrick,Lacroix Laurent,Riou Jean-François,Mergny Jean-Louis

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Biomedical Engineering,Bioengineering,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s10616-004-5127-z.pdf

Reference138 articles.

1. Triplex- versus Quadruplex-Specific Ligands and Telomerase Inhibition

2. Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase

3. Nucleic Acids as Targets for Antitelomerase Agents

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management;Human Pathology;2023-03

2. Functional G-Quadruplex Binding Molecules;Chemistry Letters;2020-07-05

3. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors;Drug Discovery Today;2019-07

4. Construction of a transcription factor‑long non‑coding RNA‑microRNA network for the identification of key regulators in lung adenocarcinoma and lung squamous cell carcinoma;Molecular Medicine Reports;2018-12-14

5. RNA interference mediated downregulation of human telomerase reverse transcriptase (hTERT) in LN18 cells;Cytotechnology;2016-10-18